MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)

– 53 participants enrolled across two sites –

...

Related Keywords

Canada ,Canadian ,Robert Barrow ,Company Phase ,Company Quarterly Report On Form ,Nasdaq ,Company Annual Report On Form ,Company Or Mindmed ,Exchange Commission ,Medicine Mindmed Inc ,Mind Medicine ,Chief Executive Officer ,Symptom Rating Scale ,Annual Report ,Quarterly Report ,Note Regarding Forward Looking Statements ,Financial Condition ,Markets ,